Night Vision Disturbances Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | Ocuphire Pharma

DelveInsight's "Night Vision Disturbances Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Night Vision Disturbances, historical and forecasted epidemiology as well as the Night Vision Disturbances market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover which therapies are expected to grab the Night Vision Disturbances Market Share @ Night Vision Disturbances Market Outlook- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Night Vision Disturbances Market Report
• In March 2025, Ocuphire Pharma Inc. announced a study of the safety and efficacy of POS (0.75% Phentolamine Ophthalmic Solution) in subjects who have previously had keratorefractive surgery and have decreased visual acuity (VA) under mesopic conditions.
• In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of Night Vision Disturbance in the 7MM were nearly 55 million in 2023.
• The highest total diagnosed prevalent cases of Night Vision Disturbance were accounted by the US in 2023 (44%), which are expected to show a rise in the future.
• Among the European countries, Germany had the highest diagnosed prevalent cases of Night Vision Disturbance with ~6 million cases, followed by France, which had diagnosed prevalent population of ~4 million in 2023. On the other hand, Spain had the lowest prevalent population (~3 million cases).
• Japan had nearly 9 million total diagnosed prevalent cases of Night Vision Disturbance in 2023, accounting for approximately 16% in 7MM.
• The increase in Night Vision Disturbances Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Night Vision Disturbances Market is anticipated to witness growth at a considerable CAGR.
• The leading Night Vision Disturbances Companies such as Ocuphire Pharma and others.
• Promising Night Vision Disturbances Pipeline Therapies such as Phentolamine Mesylate Ophthalmic Solution 1.0%, and others.

Stay ahead in the Night Vision Disturbances Therapeutics Market with DelveInsight's Strategic Report @ Night Vision Disturbances Market Outlook- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Night Vision Disturbances Epidemiology Segmentation in the 7MM
The epidemiology section of Night Vision Disturbances offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
• Total Night Vision Disturbances Diagnosed Prevalent Cases

Download the report to understand which factors are driving Night Vision Disturbances Epidemiology trends @ Night Vision Disturbances Prevalence- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Night Vision Disturbance Emerging Drugs
• Phentolamine Ophthalmic Solution 0.75% (Nyxol): Ocuphire Pharma/Viatris
Nyxol is a novel ophthalmic treatment for multiple front-of-the-eye disorders, including NVD and presbyopia. It is a proprietary ophthalmic formulation of phentolamine mesylate, an alpha-1 and alpha-2 inhibitor that has been approved previously as an injectable for other indications, allowing a more efficient development pathway for approval. Nyxol has demonstrated a differentiated product profile by moderately reducing pupil size (which leads to improved night and day vision), significantly lowering intraocular pressure, and convenient once-daily dosing. In September 2023, RYZUMVI (phentolamine ophthalmic solution) became a FDA-approved medicine to treat pharmacologically-induced mydriasis - dilation of the pupil of the eye caused by eye drops. Approval was supported by positive results in the MIRA-2 and MIRA-3 clinical trials. Ocuphire has a partnership with Viatris, Inc. to develop and commercialize phentolamine ophthalmic solution 0.75%.

Night Vision Disturbances Drugs Market
The Night Vision Disturbances Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Night Vision Disturbances signaling in Night Vision Disturbances are likely to uncover new therapeutic targets and further expand treatment options for patients.

Night Vision Disturbances Treatment Market Landscape
The Night Vision Disturbances treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Night Vision Disturbances has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Night Vision Disturbances treatment guidelines, visit @ Night Vision Disturbances Treatment Market Landscape- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Night Vision Disturbances Market Outlook
Night Vision Disturbances is a rare genetic eye disease that occurs when fatty material builds up on the macula, the small part of the retina responsible for sharp, central vision. It is caused by a mutation in the ABCA4 gene (also caused by other genes in some instances), which prevents the production of a protein that cleans up the fatty material left over from vitamin A metabolism. As a result, the fatty material accumulates in yellowish clumps on the macula, eventually killing the light-sensitive cells and destroying central vision.

Night Vision Disturbances Drugs Uptake
The drug chapter of the Night Vision Disturbances report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Night Vision Disturbances.

Major Night Vision Disturbances Companies
Ocuphire Pharma and others

Learn more about the FDA-approved drugs for Night Vision Disturbances @ Drugs for Night Vision Disturbances Treatment- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Night Vision Disturbances Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Night Vision Disturbances Companies- Ocuphire Pharma and others
• Night Vision Disturbances Pipeline Therapies- Phentolamine Mesylate Ophthalmic Solution 1.0%, and others.
• Night Vision Disturbances Market Dynamics: Night Vision Disturbances Market Drivers and Barriers
• Night Vision Disturbances Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Night Vision Disturbances Drugs in development @ Night Vision Disturbances Clinical Trials Assessment- https://www.delveinsight.com/sample-request/night-vision-disturbances-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Night Vision Disturbances Executive Summary
3. Night Vision Disturbances Competitive Intelligence Analysis
4. Night Vision Disturbances: Market Overview at a Glance
5. Night Vision Disturbances: Disease Background and Overview
6. Patient Journey
7. Night Vision Disturbances Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Night Vision Disturbances Unmet Needs
10. Key Endpoints of Night Vision Disturbances Treatment
11. Night Vision Disturbances Marketed Products
12. Night Vision Disturbances Emerging Therapies
13. Night Vision Disturbances: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Night Vision Disturbances Market Outlook
16. Access and Reimbursement Overview of Night Vision Disturbances
17. KOL Views
18. Night Vision Disturbances Market Drivers
19. Night Vision Disturbances Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2025

NK Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Psoriasis Vulgaris Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Urea Cycle Disorders Market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Immune Checkpoints Activators Market- https://www.delveinsight.com/report-store/immune-checkpoint-inhibitors-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Surgical Robotic System Market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Diabetic Wound Market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Overactive Bladder Syndrome Market- https://www.delveinsight.com/report-store/underactive-bladder-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Healthcare Competitive Benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Intraocular Lens Market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/blog/cardiac-monitoring-devices-market
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical Mask & Respirator Market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.